Multi-Drug Resistant Organism Network

CompletedOBSERVATIONAL
Enrollment

6,496

Participants

Timeline

Start Date

June 16, 2016

Primary Completion Date

May 30, 2020

Study Completion Date

May 30, 2020

Conditions
Infections Resistant to Multiple DrugsBacterial Infections
Interventions
OTHER

Standard of Care

There is no prescribed intervention for this study. Standard of care will be captured in the eCRF.

Trial Locations (4)

4029

The University of Queensland Centre for Clinical Research, Herston

27705

Duke Clinical Research Institute, Durham

200040

Huashan Hospital, Shanghai

Unknown

Universidad El Bosque, Bogotá

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Duke University

OTHER

NCT03646227 - Multi-Drug Resistant Organism Network | Biotech Hunter | Biotech Hunter